Argatroban

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 6 JDMF, 3 KDMF, 7 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 19 FDA Orange Book, 2 Europe, 1 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INJECTION - 50MG/50ML (1MG/ML), INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Actylis, 1 BASF, 1 Finar, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

11 Film Formers & Plasticizers, 5 Parenteral, 4 Taste Masking, 4 Coating Systems & Additives, 4 Fillers, Diluents & Binders, 3 Solubilizers, 3 Topical, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Co-Processed Excipients, 1 Direct Compression